A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.

Name: A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study.
Author: Gamucci, Teresa

A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study. — المؤلف: Gamucci, Teresa — Cancer biology & therapy 20200421

المؤلف: Gamucci, Teresa
النشر: Cancer biology & therapy 20200421
الوصف: 192-200 p.
الموضوعات: Antibodies, Monoclonal, Humanized؛ Antineoplastic Combined Chemotherapy Protocols؛ Breast Neoplasms؛ Female؛ Humans؛ Middle Aged؛ Retrospective Studies؛ Taxoids